Hailee F Scelsi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Escherichia Coli

Intellectual Disability

Top Venues

Disease models & mechanisms

This page only lists publications with an associated author ORCID identifier.

Publications

Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms 16 (1) (2023)
Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms 16 (1) (2023)
Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms 16 (1) (2023)
Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms 16 (1) (2023)
Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms 16 (1) (2023)
Hailee F Scelsi, Kamisha R Hill, Brett M Barlow, Mackenzie D Martin, Raquel L Lieberman
Disambiguation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability. Disease models & mechanisms (2022)
Hailee F Scelsi, Brett M Barlow, Emily G Saccuzzo, Raquel L Lieberman
Common and rare myocilin variants: Predicting glaucoma pathogenicity based on genetics, clinical, and laboratory misfolding data. Human mutation 42 (8) (2021)